Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study

被引:7
作者
Okuyama, Yoshiharu [1 ]
Hatakeyama, Shingo [2 ,7 ]
Tabata, Ryuji [3 ]
Fujimori, Daiji [3 ]
Kawashima, Yohei [3 ]
Tanaka, Toshikazu [4 ]
Fujita, Naoki [1 ]
Okamoto, Teppei [1 ]
Mori, Kazuyuki [1 ]
Yamamoto, Hayato [1 ]
Yoneyama, Takahiro [5 ]
Hashimoto, Yasuhiro [1 ]
Matsuoka, Toshimitsu [6 ]
Sato, Satoshi [3 ]
Ohyama, Chikara [1 ,2 ]
机构
[1] Hirosaki Univ, Dept Urol, Grad Sch Med, Hirosaki, Japan
[2] Hirosaki Univ, Dept Adv Blood Purificat Therapy, Grad Sch Med, Hirosaki, Japan
[3] Ageo Cent Gen Hosp, Dept Urol, Ageo, Japan
[4] Aomori Prefectural Cent Hosp, Dept Urol, Aomori, Japan
[5] Hirosaki Univ, Dept Adv Transplant & Regenerat Med, Grad Sch Med, Hirosaki, Japan
[6] Hachinohe Heiwa Hosp, Dept Urol, Hachinohe, Japan
[7] Hirosaki Univ, Dept Adv Blood Purificat Therapy, Grad Sch Med, 5 Zaifu chou, Hirosaki 0368562, Japan
基金
日本学术振兴会;
关键词
estimated glomerular filtration rate; hydronephrosis; radical nephroureterectomy; renal function; upper tract urothelial carcinoma; GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; CHEMOTHERAPY; CANCER; UNFIT;
D O I
10.1111/iju.15192
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the impact of radical nephroureterectomy on postoperative renal function in patients with upper tract urothelial carcinoma (UTUC).Methods We retrospectively evaluated 645 patients with UTUC treated with radical nephroureterectomy between January 2000 and May 2022. The primary outcome was the rate of postoperative estimated glomerular filtration rate (eGFR) = 60 mL/min/1.73 m(2). Secondary outcomes included the rate of eGFR decline, identification of factors related to eGFR decline, and the impact of comorbidities (diabetes or cardiovascular disease) on postoperative eGFR at 1 year.Results The median preoperative and postoperative eGFR levels were 55.6 and 43.3 mL/min/1.73 m(2), respectively. The rate of patients with preoperative and postoperative eGFR = 60 mL/min/1.73 m(2) was 40.9% and 9.0%, respectively. The median decline in eGFR after surgery was 25.1%. The presence of preoperative unilateral hydronephrosis and eGFR <60 mL/min/1.73 m(2) was significantly associated with a low decline of postoperative eGFR and poor survival. The impact of the presence of comorbidities on postoperative eGFR at 1 year was significant (p < 0.001).Conclusion Impaired renal function is prevalent in patients with UTUC. The rate of patients with postoperative eGFR = 60 mL/min/1.73 m(2) was 9.0%. The presence of preoperative renal impairment was significantly related to a low decline in postoperative eGFR and poor survival. The presence of comorbidities had a significant effect on eGFR decline 1 year after radical nephroureterectomy.
引用
收藏
页码:649 / 657
页数:9
相关论文
共 29 条
[21]   Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers [J].
Paner, Gladell P. ;
Stadler, Walter M. ;
Hansel, Donna E. ;
Montironi, Rodolfo ;
Lin, Daniel W. ;
Amin, Mahul B. .
EUROPEAN UROLOGY, 2018, 73 (04) :560-569
[22]   Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses [J].
Pfister, Christian ;
Gravis, Gwenaelle ;
Flechon, Aude ;
Soulie, Michel ;
Guy, Laurent ;
Laguerre, Brigitte ;
Mottet, Nicolas ;
Joly, Florence ;
Allory, Yves ;
Harter, Valentin ;
Culine, Stephane .
EUROPEAN UROLOGY, 2021, 79 (02) :214-221
[23]   European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update [J].
Roupret, Morgan ;
Babjuk, Marko ;
Burger, Maximilian ;
Capoun, Otakar ;
Cohen, Daniel ;
Comperat, Eva M. ;
Cowan, Nigel C. ;
Dominguez-Escrig, Jose L. ;
Gontero, Paolo ;
Mostafid, A. Hugh ;
Palou, Joan ;
Peyronnet, Benoit ;
Seisen, Thomas ;
Soukup, Viktor ;
Sylvester, Richard J. ;
van Rhijn, Bas W. G. ;
Zigeuner, Richard ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY, 2021, 79 (01) :62-79
[24]   Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline [J].
Stevens, Paul E. ;
Levin, Adeera .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (11) :825-+
[25]   European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines [J].
Witjes, J. Alfred ;
Bruins, Harman Max ;
Cathomas, Richard ;
Comperat, Eva M. ;
Cowan, Nigel C. ;
Gakis, Georgios ;
Hernandez, Virginia ;
Linares Espinos, Estefania ;
Lorch, Anja ;
Neuzillet, Yann ;
Rouanne, Mathieu ;
Thalmann, George N. ;
Veskimae, Erik ;
Ribal, Maria J. ;
van der Heijden, Antoine G. .
EUROPEAN UROLOGY, 2021, 79 (01) :82-104
[26]  
Xylinas E, 2013, BJU INT, V112, P453, DOI 10.1111/j.1464-410X.2012.11649.x
[27]   Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome [J].
Yafi, Faysal A. ;
Tanguay, Simon ;
Rendon, Ricardo ;
Jacobsen, Niels ;
Fairey, Adrian ;
Izawa, Jonathan ;
Kapoor, Anil ;
Black, Peter ;
Lacombe, Louis ;
Chin, Joe ;
So, Alan ;
Lattouf, Jean-Baptiste ;
Bell, David ;
Fradet, Yves ;
Saad, Fred ;
Matsumoto, Edward ;
Drachenberg, Darrel ;
Cagiannos, Ilias ;
Kassouf, Wassim .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) :31.e17-31.e24
[28]   Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study [J].
Yamada, Yukio ;
Nakagawa, Tohru ;
Miyakawa, Jimpei ;
Kawai, Taketo ;
Tabata, Mariko ;
Kaneko, Tomoyuki ;
Taguchi, Satoru ;
Naito, Akihiro ;
Hikatsu, Masahiro ;
Sato, Yusuke ;
Murata, Taro ;
Matsumoto, Akihiko ;
Miyazaki, Hideyo ;
Suzuki, Motofumi ;
Enomoto, Yutaka ;
Nishimatsu, Hiroaki ;
Kondo, Yasushi ;
Takeuchi, Takumi ;
Tanaka, Yoshinori ;
Kume, Haruki .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (10) :1577-1586
[29]   Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma [J].
Zennami, Kenji ;
Sumitomo, Makoto ;
Takahara, Kiyoshi ;
Nukaya, Takuhisa ;
Takenaka, Masashi ;
Fukaya, Kosuke ;
Ichino, Manabu ;
Fukami, Naohiko ;
Sasaki, Hitomi ;
Kusaka, Mamoru ;
Shiroki, Ryoichi .
BJU INTERNATIONAL, 2021, 127 (03) :332-339